Correlation Between Akari Therapeutics and Moleculin Biotech
Can any of the company-specific risk be diversified away by investing in both Akari Therapeutics and Moleculin Biotech at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Akari Therapeutics and Moleculin Biotech into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Akari Therapeutics PLC and Moleculin Biotech, you can compare the effects of market volatilities on Akari Therapeutics and Moleculin Biotech and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Akari Therapeutics with a short position of Moleculin Biotech. Check out your portfolio center. Please also check ongoing floating volatility patterns of Akari Therapeutics and Moleculin Biotech.
Diversification Opportunities for Akari Therapeutics and Moleculin Biotech
0.4 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Akari and Moleculin is 0.4. Overlapping area represents the amount of risk that can be diversified away by holding Akari Therapeutics PLC and Moleculin Biotech in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Moleculin Biotech and Akari Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Akari Therapeutics PLC are associated (or correlated) with Moleculin Biotech. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Moleculin Biotech has no effect on the direction of Akari Therapeutics i.e., Akari Therapeutics and Moleculin Biotech go up and down completely randomly.
Pair Corralation between Akari Therapeutics and Moleculin Biotech
Given the investment horizon of 90 days Akari Therapeutics PLC is expected to generate 0.99 times more return on investment than Moleculin Biotech. However, Akari Therapeutics PLC is 1.01 times less risky than Moleculin Biotech. It trades about 0.05 of its potential returns per unit of risk. Moleculin Biotech is currently generating about -0.42 per unit of risk. If you would invest 122.00 in Akari Therapeutics PLC on November 10, 2024 and sell it today you would earn a total of 2.00 from holding Akari Therapeutics PLC or generate 1.64% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Akari Therapeutics PLC vs. Moleculin Biotech
Performance |
| Timeline |
| Akari Therapeutics PLC |
| Moleculin Biotech |
Akari Therapeutics and Moleculin Biotech Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Akari Therapeutics and Moleculin Biotech
The main advantage of trading using opposite Akari Therapeutics and Moleculin Biotech positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Akari Therapeutics position performs unexpectedly, Moleculin Biotech can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Moleculin Biotech will offset losses from the drop in Moleculin Biotech's long position.| Akari Therapeutics vs. Armata Pharmaceuticals | Akari Therapeutics vs. Anebulo Pharmaceuticals | Akari Therapeutics vs. Processa Pharmaceuticals | Akari Therapeutics vs. Salarius Pharmaceuticals |
| Moleculin Biotech vs. Pulmatrix | Moleculin Biotech vs. Cyclacel Pharmaceuticals | Moleculin Biotech vs. Akari Therapeutics PLC | Moleculin Biotech vs. Bio Path Holdings |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.
Other Complementary Tools
| Transaction History View history of all your transactions and understand their impact on performance | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data |